121 related articles for article (PubMed ID: 31079422)
1. The role of circulating extracellular vesicles in breast cancer classification and molecular subtyping.
Platko K; Haas-Neill S; Aziz T; Al-Nedawi K
Breast J; 2019 Jul; 25(4):691-695. PubMed ID: 31079422
[TBL] [Abstract][Full Text] [Related]
2. Extracellular vesicles from young women's breast cancer patients drive increased invasion of non-malignant cells via the Focal Adhesion Kinase pathway: a proteomic approach.
Jordan KR; Hall JK; Schedin T; Borakove M; Xian JJ; Dzieciatkowska M; Lyons TR; Schedin P; Hansen KC; Borges VF
Breast Cancer Res; 2020 Nov; 22(1):128. PubMed ID: 33225939
[TBL] [Abstract][Full Text] [Related]
3. Investigating the Potential and Pitfalls of EV-Encapsulated MicroRNAs as Circulating Biomarkers of Breast Cancer.
Moloney BM; Gilligan KE; Joyce DP; O'Neill CP; O'Brien KP; Khan S; Glynn CL; Waldron RM; Maguire CM; Holian E; Naughton E; Elhadi M; Grealish AB; Malone C; McDermott E; Dockery P; Ritter T; Prina-Mello A; Kerin MJ; Dwyer RM
Cells; 2020 Jan; 9(1):. PubMed ID: 31936142
[TBL] [Abstract][Full Text] [Related]
4. Proteomic profiling of extracellular vesicles allows for human breast cancer subtyping.
Rontogianni S; Synadaki E; Li B; Liefaard MC; Lips EH; Wesseling J; Wu W; Altelaar M
Commun Biol; 2019; 2():325. PubMed ID: 31508500
[TBL] [Abstract][Full Text] [Related]
5. Relationship between erb-B2 mRNA Expression in Blood and Tissue of Invasive Ductal Carcinoma Breast Cancer Patients and Clinicopathological Characteristics of the Tumors.
Moazzezy N; Ebrahimi F; Sisakht MM; Yahyazadeh H; Bouzari S; Oloomi M
Asian Pac J Cancer Prev; 2016; 17(1):249-54. PubMed ID: 26838218
[TBL] [Abstract][Full Text] [Related]
6. IL-3R-alpha blockade inhibits tumor endothelial cell-derived extracellular vesicle (EV)-mediated vessel formation by targeting the β-catenin pathway.
Lombardo G; Gili M; Grange C; Cavallari C; Dentelli P; Togliatto G; Taverna D; Camussi G; Brizzi MF
Oncogene; 2018 Mar; 37(9):1175-1191. PubMed ID: 29238040
[TBL] [Abstract][Full Text] [Related]
7. Defining the relationship between cellular and extracellular vesicle (EV) content in breast cancer via an integrative multi-omic analysis.
Lane RE; Korbie D; Khanna KK; Mohamed A; Hill MM; Trau M
Proteomics; 2024 Jun; 24(11):e2300089. PubMed ID: 38168906
[TBL] [Abstract][Full Text] [Related]
8. Extracellular vesicles: An overview of biogenesis, function, and role in breast cancer.
Zha QB; Yao YF; Ren ZJ; Li XJ; Tang JH
Tumour Biol; 2017 Feb; 39(2):1010428317691182. PubMed ID: 28231725
[TBL] [Abstract][Full Text] [Related]
9. Impact of molecular subtypes classification concordance between preoperative core needle biopsy and surgical specimen on early breast cancer management: Single-institution experience and review of published literature.
Meattini I; Bicchierai G; Saieva C; De Benedetto D; Desideri I; Becherini C; Abdulcadir D; Vanzi E; Boeri C; Gabbrielli S; Lucci F; Sanchez L; Casella D; Bernini M; Orzalesi L; Vezzosi V; Greto D; Mangoni M; Bianchi S; Livi L; Nori J
Eur J Surg Oncol; 2017 Apr; 43(4):642-648. PubMed ID: 27889196
[TBL] [Abstract][Full Text] [Related]
10. Fluorescence Analysis of Vitamin D Receptor Status of Circulating Tumor Cells (CTCS) in Breast Cancer: From Cell Models to Metastatic Patients.
Zhang X; Hofmann S; Rack B; Harbeck N; Jeschke U; Sixou S
Int J Mol Sci; 2017 Jun; 18(6):. PubMed ID: 28632174
[TBL] [Abstract][Full Text] [Related]
11. Protein biomarkers in breast cancer-derived extracellular vesicles for use in liquid biopsies.
Li D; Lai W; Fan D; Fang Q
Am J Physiol Cell Physiol; 2021 Nov; 321(5):C779-C797. PubMed ID: 34495763
[TBL] [Abstract][Full Text] [Related]
12. Effect of macrophages on breast cancer cell proliferation, and on expression of hormone receptors, uPAR and HER-2.
Lindsten T; Hedbrant A; Ramberg A; Wijkander J; Solterbeck A; Eriksson M; Delbro D; Erlandsson A
Int J Oncol; 2017 Jul; 51(1):104-114. PubMed ID: 28498427
[TBL] [Abstract][Full Text] [Related]
13. Predicting the presence of breast cancer using circulating small RNAs, including those in the extracellular vesicles.
Koi Y; Tsutani Y; Nishiyama Y; Ueda D; Ibuki Y; Sasada S; Akita T; Masumoto N; Kadoya T; Yamamoto Y; Takahashi RU; Tanaka J; Okada M; Tahara H
Cancer Sci; 2020 Jun; 111(6):2104-2115. PubMed ID: 32215990
[TBL] [Abstract][Full Text] [Related]
14. Potential clinical relevance of uPA and PAI-1 levels in node-negative, postmenopausal breast cancer patients bearing histological grade II tumors with ER/PR expression, during an early follow-up.
Buta M; Džodić R; Đurišić I; Marković I; Vujasinović T; Markićević M; Nikolić-Vukosavljević D
Tumour Biol; 2015 Sep; 36(10):8193-200. PubMed ID: 25994573
[TBL] [Abstract][Full Text] [Related]
15. Thrombotic characteristics of extracellular vesicles derived from prostate cancer cells.
Al Saleh HA; Haas-Neill S; Al-Hashimi A; Kapoor A; Shayegan B; Austin RC; Al-Nedawi K
Prostate; 2018 Sep; 78(13):953-961. PubMed ID: 29761522
[TBL] [Abstract][Full Text] [Related]
16. Correlation of astrocyte elevated gene-1, basic-fibroblast growth factor, beta-catenin, Ki-67, tumor necrosis factor-alfa with prognostic parameters in ductal carcinomas and ductal intraepithelial neoplasms.
Erdem H; Gundogdu B; Ankarali H; Yasar M; Sener E; Oktay M; Bahadir A; Uzunlar AK; Gursan N; Ozaydin I; Sahiner C
Niger J Clin Pract; 2015; 18(5):638-43. PubMed ID: 26096243
[TBL] [Abstract][Full Text] [Related]
17. Circulating microRNA-based screening tool for breast cancer.
Frères P; Wenric S; Boukerroucha M; Fasquelle C; Thiry J; Bovy N; Struman I; Geurts P; Collignon J; Schroeder H; Kridelka F; Lifrange E; Jossa V; Bours V; Josse C; Jerusalem G
Oncotarget; 2016 Feb; 7(5):5416-28. PubMed ID: 26734993
[TBL] [Abstract][Full Text] [Related]
18. Protein microarray-based comparison of HER2, estrogen receptor, and progesterone receptor status in core biopsies and surgical specimens from FFPE breast cancer tissues.
Berg D; Langer R; Tran K; Walch A; Schuster T; Bronger H; Becker KF
Appl Immunohistochem Mol Morphol; 2011 Jul; 19(4):300-5. PubMed ID: 21293257
[TBL] [Abstract][Full Text] [Related]
19. Liquid biopsy for breast cancer using extracellular vesicles and cell-free microRNAs as biomarkers.
Ozawa PMM; Jucoski TS; Vieira E; Carvalho TM; Malheiros D; Ribeiro EMSF
Transl Res; 2020 Sep; 223():40-60. PubMed ID: 32413499
[TBL] [Abstract][Full Text] [Related]
20. Extracellular Vesicles as Biomarkers and Therapeutic Targets in Breast Cancer.
Sadovska L; Eglītis J; Linē A
Anticancer Res; 2015 Dec; 35(12):6379-90. PubMed ID: 26637847
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
